Checking in with HSBC Innovation Banking's Ryan Roller on the state of biotech, and the financing environment for both investment firms and companies
Apr 6
1 min read
He discusses opportunities and areas of caution, such as recent turbulence at FDA, and how they have been affecting companies. Plus, the environment for VC and PE firms to raise new funds, and what it means for public and private companies.
Note: HSBC Innovation Banking is a sponsor of BiotechTV
.png){kind=logo}